miltefosine has been researched along with Cutaneous Mastocytosis in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with miltefosine, but not with clobetasol, was often associated with eczematous skin irritation, which may, at least in part, be related to the formulation of miltefosine containing the potentially irritating alkanol propanediol as the vehicle." | 6.75 | Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial. ( Belloni, B; Brockow, K; Eben, R; Hartmann, B; Hartmann, K; Maurer, M; Ruëff, F; Schoepke, N; Siebenhaar, F; Staubach, P; Weber, A, 2010) |
| "Treatment with miltefosine, but not with clobetasol, was often associated with eczematous skin irritation, which may, at least in part, be related to the formulation of miltefosine containing the potentially irritating alkanol propanediol as the vehicle." | 2.75 | Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial. ( Belloni, B; Brockow, K; Eben, R; Hartmann, B; Hartmann, K; Maurer, M; Ruëff, F; Schoepke, N; Siebenhaar, F; Staubach, P; Weber, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartmann, K | 1 |
| Siebenhaar, F | 1 |
| Belloni, B | 1 |
| Brockow, K | 1 |
| Eben, R | 1 |
| Hartmann, B | 1 |
| Ruëff, F | 1 |
| Schoepke, N | 1 |
| Staubach, P | 1 |
| Weber, A | 1 |
| Maurer, M | 1 |
1 trial available for miltefosine and Cutaneous Mastocytosis
| Article | Year |
|---|---|
Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Cell Count; Clobetasol; Double-Blind | 2010 |